Steer Clear of Viberzi in Patients Who Don't Have a Gallbladder
FDA is now warning to avoid Viberzi (eluxadoline) in patients who don't have a gallbladder.
This is due to an increased risk of serious pancreatitis that can result in hospitalization or death in these patients.
You've likely seen ads promoting Viberzi for irritable bowel syndrome with diarrhea. It's an opioid agonist that works primarily in the gut at usual doses...similar to loperamide (Imodium A-D, etc).